# International Journal of Hematology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/international-journal-of-hematology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,990 |
| Citations | 97,421 |
| h-index | 100 |
| Homepage | http://www.springer.com/medicine/internal/journal/12185 |
| Open Access | false |
| ISSN-L | 0925-5710 |
| ISSNs | 0925-5710,1865-3774 |
| OpenAlex ID | https://openalex.org/S45192162 |
| Publisher | Springer Science+Business Media |
| Works | 6,100 |

## Journal papers

Showing 12 of 15.

- [Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation](https://scholariq.org/papers/prevalence-and-clinical-characteristics-of-acute-myeloid-leukemia-associated/)
- [Chinese guidelines for treatment of adult primary immune thrombocytopenia](https://scholariq.org/papers/chinese-guidelines-for-treatment-of-adult-primary-immune-thrombocytopenia/)
- [Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial](https://scholariq.org/papers/safety-and-efficacy-of-the-terminal-complement-inhibitor-eculizumab-in-japanese/)
- [Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial](https://scholariq.org/papers/long-term-efficacy-and-safety-of-eculizumab-in-japanese-patients-with-pnh-aegis/)
- [Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan](https://scholariq.org/papers/interim-analysis-of-post-marketing-surveillance-of-eculizumab-for-paroxysmal/)
- [Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan](https://scholariq.org/papers/real-world-safety-profile-of-eculizumab-in-patients-with-paroxysmal-nocturnal/)
- [Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR](https://scholariq.org/papers/effects-of-human-bone-marrow-stromal-cell-line-hfcl-on-the-proliferation/)
- [Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia](https://scholariq.org/papers/effectiveness-and-safety-of-rabbit-anti-thymocyte-globulin-in-japanese-patients/)
- [Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan](https://scholariq.org/papers/long-term-follow-up-of-patients-with-paroxysmal-nocturnal-hemoglobinuria-treated/)
- [Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria](https://scholariq.org/papers/hemolysis-induced-by-sars-cov-2-mrna-vaccination-in-patients-with-paroxysmal/)
- [Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301](https://scholariq.org/papers/phase-iii-study-of-ranimustine-cyclophosphamide-vincristine-melphalan-and/)
- [The evaluation of hTERT mRNA expression in acute leukemia children and 2 years follow-up of 40 cases](https://scholariq.org/papers/the-evaluation-of-htert-mrna-expression-in-acute-leukemia-children-and-2-years/)

## Journal top topics

Showing 8 of 25.

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.